ebola
viru
diseas
evd
devast
highli
infecti
ill
high
mortal
rate
diseas
endem
region
central
west
africa
limit
laboratori
infrastructur
train
staff
recent
west
african
evd
outbreak
unpreced
case
number
fatal
proven
region
outbreak
becom
potenti
threat
global
public
health
becam
sourc
subsequ
transmiss
event
spain
usa
urgent
need
rapid
afford
mean
detect
ebola
crucial
control
spread
evd
prevent
devast
fatal
current
diagnost
techniqu
includ
molecular
diagnost
serolog
antigen
detect
assay
timeconsum
laboratorybas
often
requir
train
personnel
special
equip
review
discuss
variou
ebola
detect
techniqu
current
use
highlight
potenti
futur
direct
pertin
develop
adopt
novel
pointofcar
diagnost
tool
final
case
made
need
develop
novel
microfluid
technolog
versatil
rapid
detect
platform
earli
detect
evd
transcriptionpolymeras
chain
reaction
rtpcr
cherpillod
et
al
protocol
involv
four
step
sampl
collectioninactiv
viral
rna
extract
revers
transcript
cdna
amplif
rtpcr
diagnosi
evd
rna
extract
whole
blood
tissu
ideal
facil
refer
nation
laboratori
howev
cdc
report
use
hot
laboratori
separ
clean
laboratori
sampl
collect
rna
process
respect
method
use
hot
laboratori
elimin
need
cumbersom
glove
box
requir
constant
electr
suppli
oper
flint
et
al
rna
tediou
work
requir
storag
prevent
degrad
sampl
contamin
also
risk
falseposit
test
result
thu
separ
extract
rtpcr
step
critic
drosten
et
al
towner
et
al
outbreak
clean
laboratori
contain
separ
room
rna
extract
genom
amplif
flint
et
al
done
reduc
potenti
contamin
inactiv
viru
decontamin
protocol
follow
typic
addit
guanidinium
thiocyan
buffer
commonli
avail
within
rtpcr
kit
rna
extract
purpos
drosten
et
al
weidmann
et
al
towner
et
al
towner
et
al
grolla
et
al
kurosaki
et
al
le
roux
et
al
pettitt
et
al
favour
afford
solut
neutral
viral
sampl
shelf
life
month
chomczynski
benefici
remot
area
ship
may
reliabl
pcrbase
amplif
requir
thermal
cycl
among
three
differ
temperatur
denatur
cdna
anneal
primer
cdna
amplifi
cdna
thermost
dna
polymeras
rtpcr
protocol
associ
procedur
requir
electr
power
suppli
remot
field
laboratori
furnish
simpl
gener
overcom
challeng
resourceconstrain
environ
grolla
et
al
report
pcr
amplif
run
convert
car
batteri
sourc
w
invert
diagnosi
fact
autom
rtpcr
machin
employ
outbreak
employ
rna
extract
rtpcr
singl
unit
assay
turnaround
min
howev
constant
power
sourc
requir
limit
assay
region
laboratori
outbreak
broadhurst
et
al
miniatur
thermocycl
platform
seek
reduc
diagnost
laboratori
burden
reduc
volum
sampl
reagent
requir
increas
sensit
speed
assay
guo
et
al
kiselinova
et
al
could
potenti
allow
remot
isol
area
struck
evd
receiv
faster
turnaround
thermal
cycl
limit
design
labonachip
loc
poc
devic
nucleic
acidbas
evd
diagnost
requir
intric
chip
infrastructur
engin
run
three
distinct
rtpcr
temperatur
establish
reagent
separ
small
scale
highthroughput
capabl
recent
miniatur
pcr
shown
potenti
overcom
limit
result
develop
novel
loc
microfluidicbas
dropletbas
amplif
technolog
khandurina
et
al
tewhey
et
al
howev
develop
similar
diagnost
platform
must
conduct
highthroughput
capabl
one
drawback
consid
rtpcr
genet
drift
associ
imperfect
natur
ebola
rnadepend
dna
polymeras
l
enzym
known
low
fidel
suzuki
et
al
report
high
mutat
rate
averag
substitut
per
site
per
year
viral
gp
gene
suzuki
gojobori
outbreak
sabeti
et
al
use
genom
surveil
determin
recent
outbreak
show
mutat
rate
substitut
per
site
per
year
gire
et
al
accumul
mutat
alter
sequenc
viral
genom
reduc
specif
rtpcr
primer
thu
everi
new
outbreak
potenti
reduc
sensit
due
reduc
primer
recognit
mutat
viral
genom
thu
initi
critic
genom
sequenc
suspect
viral
pathogen
done
confirm
efficaci
exist
molecular
diagnost
kit
gire
et
al
silico
model
use
sequenc
evd
patient
sampl
compar
current
rtpcr
evd
assay
kit
use
found
genom
shift
influenc
falseposit
falseneg
result
sozhamannan
et
al
assay
perform
differ
model
similar
result
primer
made
makona
kikwit
evdcaus
strain
henc
develop
multitud
specif
primer
optim
approach
identifi
differ
speci
strain
ebola
crucial
improv
accuraci
diagnosi
new
outbreak
realtim
quantit
rtpcr
rtqpcr
integr
sever
protocol
involv
fluorogen
probe
taqman
system
weidmann
et
al
trombley
et
al
huang
et
al
pettitt
et
al
less
expens
intercal
fluorophor
like
sybr
green
saijo
et
al
taqman
system
use
piec
cdna
report
quencher
dye
allow
direct
quantit
viral
rna
heid
et
al
pfaffl
depend
revers
transcriptas
enzym
util
rtqpcr
may
possess
variabl
specif
differ
segment
viral
rna
variabl
specif
revers
transcriptas
enzym
viral
rna
potenti
result
synthesi
vari
level
cdna
levesquesergeri
et
al
especi
problemat
rtpcr
quantit
purpos
order
sound
diagnost
assay
reproduc
specif
valid
current
rtqpcr
use
standard
quantifi
viral
infect
clinic
set
adopt
wide
rang
assay
use
outbreak
current
gold
standard
evd
diagnosi
use
rtpcr
techniqu
follow
onestep
twostep
rtpcr
protocol
vari
amplif
method
chemistri
addit
flexibl
protocol
result
sever
benefit
disadvantag
depend
field
situat
grolla
et
al
towner
et
al
twostep
process
first
revers
transcriptas
enzym
complementari
primer
ad
purifi
viral
rna
extract
buffer
solut
produc
cdna
carri
revers
transcript
reaction
cycl
separ
tube
polymeras
chain
reaction
prepar
ad
cdna
along
forward
revers
primer
thermost
dna
polymeras
subject
amplif
reaction
cycl
towner
et
al
grolla
et
al
one
major
advantag
twostep
method
entir
viral
genom
copi
cdna
control
set
pcr
step
number
viral
copi
accur
quantifi
infect
patient
use
fluorogen
dye
towner
et
al
util
taqman
system
cdna
quantif
potenti
patient
outcom
predictor
quantifi
rna
transcript
titr
cdna
amplif
found
patient
surviv
titr
less
rna
copiesml
howev
note
disadvantag
twostep
method
requir
transfer
newli
synthes
cdna
extract
new
tube
pcr
reaction
therebi
requir
addit
time
prepar
load
pcr
reagent
report
outbreak
use
rtpcr
allow
averag
sampl
test
day
flint
et
al
equat
almost
sampl
process
day
averag
confirm
case
throughput
assay
could
increas
potenti
mani
patient
sampl
could
process
daili
also
potenti
contamin
degrad
sampl
denatur
cdna
sampl
handl
manipul
could
lead
falseneg
result
thu
laboratori
personnel
must
train
handl
sampl
ensur
accur
result
onestep
rtqpcr
protocol
modul
perform
revers
transcript
well
cdna
amplif
singl
step
revers
transcriptas
enzym
along
dna
polymeras
mix
fluorogen
dye
reaction
cycl
occur
revers
transcript
cdna
amplif
respect
drosten
et
al
towner
et
al
weidmann
et
al
saijo
et
al
advantag
method
prevent
possibl
contamin
combin
revers
transcript
pcr
amplif
herein
elimin
need
run
separ
pcr
amplif
step
combin
step
rtpcr
reaction
reduc
process
time
allow
diagnost
turnaround
singl
step
rtqpcr
techniqu
also
high
sensit
viral
rna
forward
revers
primer
scheme
detect
threshold
rna
copiesml
towner
et
al
could
use
earlier
window
diagnosi
howev
disadvantag
onestep
method
inclus
revers
transcript
reaction
cdna
amplif
reaction
result
variat
amount
cdna
copi
revers
transcript
unlik
twostep
method
lack
control
revers
transcript
reaction
result
vari
amount
cdna
copi
amplifi
depend
enzym
affin
levesquesergeri
et
al
may
limit
onestep
method
potenti
quantit
purpos
requir
constant
level
synthes
cdna
despit
limit
onestep
rtpcr
shown
high
sensit
detect
ebov
compar
diagnost
techniqu
potenti
util
highli
sensit
earli
diagnost
purpos
tabl
list
relev
molecular
diagnost
test
deploy
recent
outbreak
show
onestep
rtpcr
method
predomin
clinic
set
nest
rtpcr
offshoot
technolog
pcr
util
highli
accur
specif
techniqu
involv
two
primer
set
amplifi
precis
exact
region
viral
rna
method
use
two
set
primer
specif
region
cdna
amplifi
larger
rna
segment
first
primer
design
outsid
flank
region
viral
rna
target
bind
amplifi
onestep
rtpcr
reaction
result
amplifi
target
product
extran
flank
trailer
region
second
primer
bind
specif
target
cdna
promotor
result
target
sequenc
amplif
second
round
pcr
creat
highli
amplifi
target
product
achiev
detect
even
small
concentr
genom
materi
increas
test
sensit
nest
rtpcr
use
target
conserv
ebov
np
gene
success
towner
et
al
advantag
nest
rtpcr
specif
target
site
amplifi
result
mass
amplif
specif
viral
target
sequenc
process
overal
reduc
amount
nonspecif
primer
bind
improv
test
accuraci
disadvantag
nest
rtpcr
risk
contamin
addit
step
ad
second
primer
set
produc
falseposit
risk
lab
contamin
exposur
drosten
et
al
nest
reaction
accur
mean
amplif
reduct
nonspecif
primer
bind
use
accur
mean
quantit
porterjordan
et
al
thu
earli
detect
either
onestep
nest
rtpcr
may
consid
reduc
assay
time
technic
burden
onestep
method
mayb
prefer
last
decad
loopmedi
isotherm
amplif
lamp
emerg
effici
rapid
mean
genom
diagnost
infecti
diseas
safavieh
et
al
similar
onestep
rtpcr
rtlamp
assay
conduct
one
step
initi
revers
transcript
target
rna
cdna
perform
prior
pcr
amplif
reaction
proce
use
polymeras
safavieh
et
al
set
four
dna
primer
kurosaki
et
al
figur
inner
primer
bip
softwaregener
primer
design
homolog
region
target
viral
rna
gene
bind
rna
hang
fragment
fragment
also
exact
sequenc
region
near
target
rna
adjac
bind
site
outer
primer
bind
displac
newli
form
cdna
dna
polymeras
copi
new
cdna
strand
displac
cdna
strand
contain
complimentari
sequenc
hang
bind
togeth
form
loopend
mori
notomi
reaction
continu
opposit
direct
anoth
set
inner
primer
fip
bind
displac
cdna
bind
site
dna
polymeras
copi
dna
copi
rna
templat
outer
primer
anoth
outer
primer
bind
segment
dna
polymeras
copi
new
strand
displac
cdna
rna
strand
cdna
copi
amplif
proceed
use
methodolog
overlap
complementari
fragment
anneal
amplif
continu
creat
long
chain
hairpin
dna
mori
notomi
rtlamp
show
great
promis
diseas
detect
remot
resourcelimit
area
rtlamp
reaction
occur
constant
temperatur
condit
safavieh
et
al
differ
normal
pcr
amplif
reaction
cycl
use
multipl
temperatur
fluctuat
onlin
databas
provid
catalog
primer
facilit
process
primer
select
design
lamp
reagent
store
powder
form
refrigerationfre
condit
reconstitut
use
point
need
kurosaki
et
al
develop
test
rtlamp
design
test
ebola
viral
genom
use
green
fluoresc
proteintag
could
amplifi
copi
viral
rna
vitro
could
also
amplifi
viral
gene
product
ffu
kurosaki
et
al
thu
novel
technolog
promis
loc
diagnost
method
miniatur
appli
real
world
scenario
due
isotherm
requir
fact
least
one
lampbas
diagnost
assay
develop
evd
outbreak
whitehous
et
al
alreadi
show
high
sensit
vitro
ebola
detect
potenti
remot
field
capabl
integr
microor
nanoscal
technolog
make
rtlamp
potenti
nextgener
genom
diagnost
tool
evd
despit
use
rtlamp
assay
platform
clinic
valid
diagnost
use
outbreak
condit
futur
work
done
verifi
rtlamp
sensit
assay
evd
clinic
set
earliest
appear
viral
antigen
postonset
symptom
titr
shown
decreas
disappear
within
diseas
onset
serolog
techniqu
develop
detect
ebov
key
indic
infect
critic
diagnost
tool
outbreak
epidem
use
serolog
diagnosi
provid
accur
rapid
mean
detect
use
directli
tissu
patient
blood
sampl
patient
sampl
test
either
quantif
viral
particl
measur
patient
immun
respons
titr
grolla
et
al
variou
antigen
antibodi
use
ebov
detect
assay
shown
tabl
discoveri
new
antiebola
antibodi
patient
plasma
serum
synthet
monoclon
antibodi
provid
sensit
mean
viru
detect
mean
map
viral
epitop
antiebola
antibodi
niikura
et
al
shahhosseini
et
al
analyz
tempor
distribut
viral
antigen
express
nanbo
et
al
demonstr
cross
reactiv
human
antiebola
antibodi
show
promis
develop
rapid
sensit
serolog
devic
poc
evd
detect
current
diagnost
protocol
recommend
rtpcr
predomin
diagnost
method
evd
towner
et
al
grolla
et
al
feldmann
geisbert
gire
et
al
cherpillod
et
al
howev
push
develop
divers
serolog
diagnost
system
portabl
reliabl
use
portal
assay
evd
chua
et
al
standard
earli
diagnost
protocol
antigen
detect
patient
serum
antigencaptur
enzymelink
immunosorb
assay
elisa
cdc
refer
sandwich
elisa
assay
well
coat
antibodi
select
viral
antigen
initi
well
rins
milkpb
prevent
nonspecif
bind
site
antibodi
kallstrom
et
al
reduc
falseposit
result
infect
serum
tissu
sampl
process
load
well
incub
allow
optim
antibodyepitop
bind
unbound
excess
sampl
remov
subsequ
rins
step
anoth
antibodi
direct
target
antigen
ad
well
incub
thu
complet
sandwich
sandwich
form
indic
antibodi
specif
previou
antibodi
ad
well
incub
antibodi
conjug
enzymat
indic
specif
fluorogen
dye
report
substrat
bind
sandwich
antibodi
complex
final
rins
colorogen
substrat
ad
well
visual
reactiv
result
indic
posit
test
antigen
captur
system
extrem
pertin
earli
stage
diagnosi
evd
infect
howev
typic
give
result
h
diagnosi
made
rtpcr
towner
et
al
thu
rtpcr
effect
diagnost
test
abl
identifi
case
sooner
standard
elisabas
serolog
test
despit
antigen
captur
assay
also
use
earli
evd
detect
due
simplic
elisa
protocol
compar
rtpcr
towner
et
al
demonstr
antigen
titr
highest
postonset
ill
fatal
nonfat
outcom
thu
antigen
detect
evd
hold
potenti
rapid
earli
poc
diagnost
develop
howev
biohazard
limit
antigen
collect
hinder
abil
verifi
valid
typic
antigen
detect
method
must
perform
typic
refer
nation
laboratori
ideal
resourcelimit
condit
variou
antigen
detect
method
also
evalu
confirmatori
diagnosi
ebola
hemorrhag
fever
ehf
immunohistochem
assay
zaki
et
al
develop
offer
rapid
simplist
diagnost
test
novel
immunofiltr
test
eboz
develop
lucht
et
al
abl
detect
viral
infect
rapidli
within
min
without
requir
electr
suppli
similar
sensit
elisa
later
flow
assay
leverag
metal
reaction
enhanc
sensit
higher
sensit
report
use
silver
nanoparticl
evd
detect
yen
et
al
tabl
document
current
antigen
detect
later
flow
assay
platform
develop
poc
diagnosi
evd
assay
perform
microlitr
sampl
volum
give
rapid
assay
turnaround
time
rapid
straightforward
techniqu
optim
field
diagnosi
ehf
poc
set
fluoresc
antibodi
techniqu
fat
also
use
previou
evd
outbreak
boure
bergmann
ksiazek
west
et
al
nanbo
et
al
method
use
epidemiolog
studi
refer
nation
laboratori
potenti
use
survey
prevent
evd
outbreak
zaki
et
al
howev
sensit
procedur
technic
fat
may
compar
favour
today
standard
elisa
ksiazek
west
et
al
final
emerg
field
serolog
evd
detect
later
flow
immunoassay
broadhurst
et
al
perkin
kessel
offer
opportun
miniatur
current
elisa
immunoassay
potenti
portabl
autom
reliabl
constraint
highli
sensit
assay
develop
exampl
reebov
antigen
rapid
kit
corgenix
sensit
specif
compar
convent
rtpcr
evd
broadhurst
et
al
limit
amount
patient
outbreak
thu
antigen
detect
platform
possess
signific
potenti
develop
futur
evd
poc
diagnost
must
valid
clinic
diagnosi
outbreak
set
broadhurst
et
al
detect
antiebola
antibodi
igmigg
elisa
anoth
effect
diagnost
tool
ksiazek
west
et
al
nakayama
et
al
earli
stage
infect
bodi
produc
igm
respons
howev
antiebola
igm
antibodi
rapidli
degener
earliest
postonset
infect
ksiazek
west
et
al
igm
antibodi
present
earliest
postonset
symptom
igg
titr
develop
postonset
symptom
respect
grolla
et
al
despit
variabl
igm
typic
present
nonfat
evd
case
postonset
symptom
broadhurst
et
al
furthermor
peopl
evd
surviv
often
die
mount
proper
humour
immun
respons
suggest
antibodybas
detect
system
ebola
may
use
antigenbas
viral
isol
method
grolla
et
al
sinc
igg
antibodi
develop
day
diseas
onset
antiebola
viru
igg
antibodi
detect
may
use
earli
diagnost
tool
may
suggest
serv
epidemiolog
surveil
marker
retest
encourag
serum
sampl
rise
igg
fall
igm
titr
suggest
ebola
diagnosi
grolla
et
al
antibodi
captur
system
util
similar
protocol
use
antigen
captur
elisa
howev
purifi
viral
antigen
place
well
captur
detect
antibodi
igm
elisa
system
develop
ksiazek
et
al
shown
detect
antiebola
igm
antibodi
reliabl
within
postinfect
ksiazek
west
et
al
howev
method
show
specif
restv
eboz
sudv
speci
result
show
disadvantag
antibodybas
detect
antiebola
antibodi
confer
epitop
conform
captur
antigen
furthermor
ksiazek
west
et
al
found
antigen
detect
predomin
mean
elisabas
ebola
detect
compar
antibodi
detect
term
sensit
time
subtl
differ
speciesspecif
viral
antigen
prevent
recognit
target
antibodi
pose
limit
design
antibodybas
detect
system
capabl
captur
differ
speci
strain
ebola
recent
advanc
recombin
dna
technolog
monoclon
antibodi
synthes
vitro
ebola
viral
antigen
antiebola
antibodi
prehaud
et
al
niikura
et
al
ikegami
et
al
lucht
et
al
lucht
et
al
nakayama
et
al
saijo
et
al
antibodi
specif
direct
variou
viral
epitop
integr
part
cut
edg
ebola
diagnost
develop
synthet
biolog
sever
experi
perform
use
recombin
protein
ebola
viru
produc
antibodi
direct
viral
antigen
prehaud
et
al
saijo
et
al
lucht
et
al
describ
monoclon
antibodi
system
protein
least
six
nine
differ
monoclon
subclass
react
four
differ
ebov
speci
eboz
sudv
tafv
restv
anoth
experi
also
demonstr
success
elisa
system
sensit
serum
titr
detect
envelop
gp
lucht
et
al
saijo
et
al
also
found
viral
antigen
detect
recombin
proteinbas
system
antibodi
even
crossreact
ebov
speci
changula
et
al
develop
antiebola
monoclon
antibodi
speciesspecif
np
map
epitop
gener
three
antibodi
crossreact
studi
facilit
develop
array
antibodi
show
necess
map
epitop
mean
implement
system
capabl
broad
recognit
ebov
antigen
anoth
monoclon
antibodi
system
develop
nakayama
et
al
show
low
crossreact
heterolog
antibodi
direct
speciesspecif
gp
elisa
could
develop
speciesspecif
antibodi
test
use
multipl
set
monoclon
antibodi
instead
one
enhanc
abil
rapidli
diagnos
evd
shahhosseini
et
al
produc
differ
monoclon
antibodi
direct
ebola
viruslikeparticl
fragment
gp
abl
determin
two
antibodi
suitabl
earli
detect
monoclon
antibodi
develop
ebola
antigen
led
potenti
speciesspecif
conserv
epitop
hold
potenti
use
diagnost
platform
evd
detect
despit
assay
use
antibodi
rais
recombin
ebola
viru
antigen
valid
clinic
diagnosi
evd
studi
bind
antibodi
ebov
antigen
done
elucid
bind
conform
epitop
confer
potenti
activ
neutral
give
immunolog
protect
structur
studi
gp
shown
contain
trimer
mucinlik
domain
nearli
half
densiti
entir
protein
may
key
understand
immun
evas
conform
modif
viral
entri
lee
et
al
lee
saphir
structur
studi
offer
immens
contribut
optim
antibodi
select
diagnost
devic
understand
biochem
complex
viral
protein
elucid
success
antiebola
antibodi
technolog
implement
epitop
map
standard
find
develop
effici
monoclon
antibodyderiv
rapid
detect
system
discoveri
advanc
biosensor
technolog
hirsch
et
al
cooper
singleton
chamber
et
al
wang
asghar
ilya
billo
et
al
asghar
ilya
deshmukh
et
al
wan
et
al
wang
et
al
applic
exploit
physic
electrochem
properti
micro
nanoscal
endless
potenti
futur
poc
biosensor
earli
rapid
diagnost
biosensor
consist
particular
recognit
element
specif
sampl
interfac
signal
transduct
amplifi
signal
respons
chamber
et
al
rollin
et
al
develop
paperbas
assay
util
biosensor
synthet
gene
circuit
develop
speciesspecif
ebov
detect
twelv
bp
region
np
mrna
transcript
sensor
fabric
per
test
detect
littl
nm
cellfre
ebov
extract
use
function
lacz
gene
increas
sensit
system
parde
et
al
push
novel
biosensor
technolog
result
creation
inexpens
rapid
detect
devic
evd
thu
area
novel
biosensor
show
promis
futur
clinic
evd
diagnost
poc
level
leverag
miniatur
biosign
process
amplif
novel
technolog
emerg
lead
potenti
new
diagnost
poc
method
evd
molecular
genom
diagnost
assay
variou
stage
develop
four
complet
autom
perkin
kessel
similarli
least
seven
later
flow
antigen
detect
assay
develop
potenti
poc
capabl
may
limit
sensit
perkin
kessel
sever
advantag
aris
integr
multipl
process
onachip
show
greater
potenti
develop
rapid
reliabl
diagnost
platform
case
decentr
poc
test
assess
result
recent
outbreak
chua
et
al
devic
focu
decentr
scheme
advantag
laboratori
constrain
remot
region
potenti
elimin
need
sampl
transport
delay
test
desir
evd
diagnosi
platform
done
threestep
less
assay
either
qualit
quantit
accept
clinic
sensit
greater
within
first
clinic
present
miniatur
loc
diagnost
method
ensur
significantli
smaller
sampl
volum
util
reduc
amount
time
process
analyz
sampl
potenti
fulli
autom
advantag
term
throughput
recommend
desir
assay
run
time
min
chua
et
al
immens
potenti
danger
biosafeti
must
also
consid
thu
still
essenti
perform
assay
typic
ppe
chua
et
al
perkin
kessel
thu
valid
even
stringent
vitro
test
diagnost
loc
assay
may
difficult
due
limit
access
potenti
hazard
exposur
work
viru
vitro
field
would
requir
biosafeti
ppe
chua
et
al
despit
emerg
author
grant
outbreak
fda
ebola
diagnost
devic
whitehous
et
al
prompt
need
develop
intern
protocol
humanitarian
intervent
use
unapprov
medic
devic
show
promis
deploy
rapid
poc
diagnost
singh
method
paperbas
microfluid
also
consid
develop
highthroughput
diagnost
shafie
et
al
recent
breakthrough
paperbas
microfluid
shown
allow
longer
shelf
life
potenti
diagnost
store
least
month
room
temperatur
afford
technolog
potenti
lessen
logist
financi
strain
seen
overwhelm
spread
evd
outbreak
bausch
schwarz
kalra
et
al
anoth
potenti
advantag
develop
loc
devic
abil
realtim
interfac
data
pool
system
way
spread
evd
could
track
power
epidemiolog
tool
potenti
help
contain
spread
viru
tambo
et
al
prevent
loss
life
therebi
reduc
neg
socioeconom
impact
affect
region
use
decentr
test
thu
develop
portabl
rapid
evd
detect
method
use
altern
technolog
show
promis
tool
forefront
evd
diagnosi
contain
control
futur
evd
outbreak
shift
decentralizedfavour
test
critic
control
spread
diseas
region
recent
outbreak
occur
howev
also
equal
pose
challeng
assay
valid
clinic
set
futur
clinic
test
stringent
protocol
develop
test
novel
method
detect
place
valid
poc
platform
develop
magnet
particl
function
antibodi
leverag
autom
detect
platform
bhalla
et
al
lien
et
al
yun
et
al
autom
standard
test
render
handsfre
use
microfluid
platform
less
sampl
reagent
consum
recent
elisa
develop
poc
platform
figur
actuat
magnet
bead
function
antibodi
show
great
potenti
rapid
detect
hiv
wang
et
al
anoth
magneticbeadbas
method
use
isol
sle
antidna
antibodi
cavallo
et
al
pavlov
et
al
onchip
dna
bind
assay
use
biotinstreptavidin
function
magnet
bead
develop
manipul
captur
eboz
rna
stain
abl
detect
pfuml
cai
et
al
technolog
show
benefit
magnet
bead
actuat
nucleic
acid
detect
ebola
report
demonstr
wide
versatil
magnet
bead
actuat
diagnost
devic
lead
potenti
devic
autom
rapid
diagnost
technolog
essenti
quickli
contain
spread
infecti
diseas
specif
ebov
antigen
could
also
target
function
magnet
bead
potenti
autom
platform
use
resourcelimit
area
limit
number
fatal
neg
socioeconom
impact
caus
dissemin
evd
nucleic
acid
extract
purif
critic
step
requir
genom
diagnosi
method
pcr
rtpcr
lamp
extract
nucleic
acid
typic
perform
seri
organ
separ
limit
applic
poc
test
develop
capillari
electrophoresi
ce
techniqu
rossomando
et
al
woolley
et
al
techniqu
separ
migrat
sampl
trap
lead
trail
buffer
electrophoret
interphas
constant
electr
field
appli
channel
modifi
cebas
method
isotachophoresi
itp
simpler
design
figur
b
reli
similar
ce
separ
strategi
persat
et
al
young
et
al
jung
et
al
garciaschwarz
et
al
versatil
platform
develop
loc
wide
rang
nucleic
acid
separ
diagnost
applic
rna
extract
bacteria
dna
isol
hepat
b
viru
liu
et
al
dna
extract
malaria
parasit
plasmodium
infect
erythrocyt
marshal
et
al
isol
nucleic
acid
also
amplifi
onachip
liu
et
al
use
dna
amplif
method
ostromohov
et
al
describ
devic
combin
itp
preconcentr
target
sampl
pna
probe
chip
potenti
diseas
detect
develop
devic
shown
sensit
concentr
low
pm
sampl
dna
target
run
min
ostromohov
et
al
rapid
devic
runtim
abil
leverag
innov
extract
method
chip
downstream
genom
applic
highthroughput
nucleic
acid
test
ebola
could
establish
novel
microfluid
devic
past
two
decad
variou
pna
probe
develop
use
tool
enumer
character
microb
environment
biolog
ecolog
esiobu
et
al
pna
probe
offer
greater
accuraci
compar
dnabas
oligonucleotid
probe
system
li
et
al
pna
probe
util
polyamid
backbon
mimic
dna
pentosephosphodiest
backbon
even
show
superior
bind
target
dna
rna
compar
tradit
nucleic
acid
probe
pna
inher
backbon
charg
may
prevent
hybrid
brandt
hoheisel
chamber
et
al
probe
also
advantag
due
rel
thermal
stabil
compar
dnadna
hybrid
allow
easi
develop
poc
diagnost
system
zhang
appella
addit
pna
probe
design
bind
rna
directli
sinc
ebola
negativestrand
rna
viru
technolog
elimin
need
cdna
synthesi
thermalcycl
platform
thu
pna
test
suitabl
candid
resourceconstrain
region
could
potenti
appli
poc
diagnost
devic
ipcr
nextgener
biotechnolog
incorpor
genom
serolog
techniqu
creat
sensit
diagnost
tool
figur
b
assay
util
primer
tag
end
amplifi
pcr
amplifi
tag
captur
elisa
system
result
highli
sensit
test
abl
detect
antigen
molecul
sano
et
al
ipcr
implement
evalu
limit
detect
bacteri
toxin
prion
protein
bacteri
antigen
viral
antigen
malou
raoult
anoth
variant
realtimeipcr
shown
greater
sensit
accuraci
viral
detect
barletta
show
great
potenti
applic
earli
rapid
detect
ebola
exampl
morin
et
al
implement
realtimeipcr
system
detect
influenza
anoth
singlestrand
rna
viru
rang
picomol
morin
schaeffer
suggest
ipcr
sensit
precursor
elisa
fact
shown
time
sensit
chamber
et
al
despit
need
carri
pcr
reaction
amplif
thermocycl
develop
describ
implement
ipcr
microfluid
channel
chamber
et
al
show
promis
develop
microfluid
ipcr
poc
technolog
could
show
potenti
evd
diagnosi
spr
qcmbase
biosens
technolog
show
great
promis
develop
poc
assay
method
labelfre
figur
b
yu
et
al
develop
spr
qcm
immunosensor
detect
ebola
viru
gp
monoclon
polyclon
antibodi
experi
sensit
greatli
increas
integr
discret
biosens
technolog
along
use
broad
rang
multipl
monoclon
polyclon
antibodi
possibl
qcm
gold
electrod
antibodi
captur
matrix
optic
sourc
laser
crystal
frequenc
resist
measur
collect
absorpt
spectrum
measur
differ
baselin
reaction
absorb
qcm
abl
detect
fluctuat
absorb
concentr
nm
eboz
sudv
gp
respect
yu
et
al
suggest
qcm
biosensor
potenti
develop
poc
set
may
result
devic
low
implement
cost
qcm
labelfre
technolog
requir
stain
antibodi
use
elisa
yet
highli
sensit
detect
surfac
plasmon
refer
surfac
electromagnet
wave
propag
parallel
along
metal
dielectr
interfac
wave
caus
discret
fluctuat
electron
densiti
boundari
metal
glass
typic
platform
consist
conduct
metal
layer
gold
sampl
captur
layer
function
antibodi
aptam
spr
platform
antiebola
antibodi
coat
onto
sensor
chip
consist
gold
plate
interfac
matrix
antibodi
bind
yu
et
al
ebola
antigen
bind
function
gold
surfac
produc
chang
plasmon
electron
densiti
fluctuat
henc
show
differ
absorpt
spectra
extinct
intens
spectra
light
sourc
appli
allow
highli
discret
sens
viral
antigen
recent
microcav
fabric
integr
nanoplasmonicphoton
use
gold
nanoshel
detect
smallest
known
rna
viru
dantham
et
al
implic
surfac
plasmon
potenti
benefici
technolog
viru
detect
could
implement
detect
ebov
exist
nm
length
comparison
nm
viru
strauss
sinsheim
nanostructur
photon
crystalbas
labelfre
biosensor
also
develop
captur
quantifi
hiv
viral
load
figur
c
shafie
et
al
surfacecaptur
virus
produc
shift
reson
peak
wavelength
valu
enabl
detect
viru
copiesml
labelfre
loc
platform
develop
opticalcryst
plasmonicsbas
system
shown
pertin
tool
ebov
detect
show
potenti
futur
evd
poc
diagnost
test
yu
et
al
electr
sens
modal
elimin
need
bulki
equip
requir
opticalbas
detect
system
power
sensit
technolog
develop
poc
diagnost
assay
recent
paper
microchip
print
electrod
develop
detect
quantifi
multipl
pathogen
includ
multipl
hiv
subtyp
b
c
e
g
kaposi
sarcomaassoci
herp
viru
kshv
epsteinbarr
viru
ebv
e
coli
fingerprick
volum
plasma
artifici
saliva
sampl
biolog
relev
concentr
use
electr
sens
viral
lysat
shafie
asghar
et
al
shafie
h
kanakasabapathi
et
al
biosens
strategi
may
also
use
develop
labelfre
poc
diagnost
assay
ebov
detect
detect
protein
biomark
nanogap
break
junction
function
targetspecif
aptam
develop
nanobreak
junction
detect
captur
target
molecul
measur
chang
electr
current
across
gap
fabric
narrow
breakjunct
biomark
concentr
region
flow
channel
easili
detect
figur
asghar
et
al
specif
biomark
ebov
potenti
captur
detect
function
nanogap
bin
et
al
develop
rna
aptam
specif
eboz
doublestrand
rna
bind
protein
potenti
drug
besid
therapeut
valu
aptam
could
also
immobil
nanobreak
junction
develop
potenti
labelfre
tool
rapid
evd
diagnosi
poc
electr
signalbas
diagnost
includ
antibodyfunction
nanowir
array
measur
chang
conduct
previous
shown
success
detect
influenza
patolski
et
al
devic
provid
altern
highli
discret
labelfre
method
electr
detect
measur
chang
electr
conduct
hold
potenti
captur
detect
ebov
poc
set
expand
field
nanotechnolog
demonstr
vast
array
biosensor
tool
avail
vidyala
et
al
hafeez
et
al
ilya
asghar
ahm
et
al
asghar
et
al
rappa
et
al
safavieh
et
al
safavieh
et
al
sher
et
al
integr
accur
sensit
method
detect
ebola
current
convent
idea
miniatur
scale
run
diagnost
platform
advent
variou
serolog
assay
nucleic
acid
amplif
techniqu
lagal
et
al
lutz
et
al
integr
onachip
demonstr
success
assimil
convent
serolog
nucleic
acid
detect
method
sun
et
al
creat
loc
devic
detect
viral
rna
influenza
use
nucleic
acid
separ
rtpcr
microarray
separ
next
gener
handheld
poc
devic
leverag
sever
differ
array
test
truli
defin
standard
loc
diagnost
gaster
et
al
develop
devic
call
nanolab
capabl
deploy
individu
use
potenti
resourcelimit
area
around
world
diseas
detect
complex
miniatur
convent
laboratori
experi
detect
reduc
significantli
time
autom
miniatur
lead
effici
sampl
reagent
consumpt
drive
creation
novel
nextgener
highthroughput
diagnost
system
evd
review
perform
exhaust
analysi
benefit
limit
variou
convent
possibl
nonconvent
diagnost
method
evd
detect
demonstr
use
novel
biosensor
leverag
potenti
diagnost
microfluid
platform
compar
effort
logist
cost
effect
reliabl
poc
devic
favour
becom
vanguard
diagnost
platform
show
great
valu
area
affect
evd
tradit
method
ebov
detect
reli
avail
necessari
reagent
requir
close
contact
infect
sampl
motiv
concern
develop
safe
effici
method
rtpcr
sensit
requir
sever
tightli
control
process
obtain
reliabl
result
numer
technolog
present
potenti
capabl
meet
drawback
first
rna
process
potenti
simplifi
leverag
advantag
mani
new
differ
devic
fabric
techniqu
incorpor
isol
detect
nucleic
acid
assay
design
autom
perform
rapidli
poc
set
potenti
increas
sensit
molecularbas
assay
elisa
serolog
method
highli
sensit
method
detect
evd
highli
specif
differ
ebola
viru
speci
strain
howev
sensit
assay
met
success
current
rtpcr
method
potenti
increas
sensit
nanotechnolog
novel
locbas
sens
platform
sever
diagnost
assay
use
molecular
serolog
detect
employ
emerg
author
west
african
evd
outbreak
demonstr
global
shift
toward
implant
pointofcar
test
help
control
spread
evd
portabl
reliabl
loc
technolog
achiev
higher
sensit
quicker
assay
turnaround
time
leverag
mani
futur
diagnost
advanc
describ
advanc
reduc
sampl
reagent
volum
decreas
assay
cost
provid
develop
assay
util
novel
detect
method
compar
previous
valid
evd
kit
particular
rtpcr
howev
lack
essenti
diagnost
perform
clinic
test
outbreak
set
futur
assay
subject
test
experiment
use
parallel
establish
evd
diagnosi
protocol
valid
viabl
assay
futur
evd
outbreak
demonstr
event
prior
detect
threshold
green
orang
particl
repres
common
serolog
target
gp
respect
viral
rna
repres
blue
red
transcript
reprint
copyright
permiss
roca
et
al
rtlamp
final
cyclic
reaction
elong
step
follow
fip
primer
bind
anoth
round
polymer
revers
transcriptas
bind
fip
primer
make
cdna
copi
step
continu
bip
primer
make
templat
dna
strand
cdna
polymer
outsid
reaction
repeat
multipl
round
allow
mass
amplif
ebola
rna
target
reprint
copyright
permiss
notomi
et
al
b
result
rtlamp
ebola
kurosaki
et
al
show
sensit
amplifi
vitro
ebola
rna
copi
c
durat
ebola
genom
amplif
rtlamp
shown
detect
ebola
within
min
reprint
copyright
permiss
kurosaki
et
al
magnet
bead
actuat
chip
wholeblood
sampl
isotachophoresi
function
magnet
bead
hiv
elisa
detect
assay
magnet
bead
bind
captur
cell
actuat
reaction
chamber
magnet
field
appli
colour
chang
indic
seroposit
reaction
final
well
reprint
copyright
permiss
wang
et
al
b
complex
isotachophoresi
onachip
design
captur
isol
parasit
dna
infect
leukocyt
use
electr
field
gener
electrophoret
separ
ionic
sampl
reprint
copyright
permiss
marshal
et
al
altern
biosens
technolog
rapid
earli
diagnosi
ebola
quartz
crystal
microbal
immunosensor
compos
gold
electrod
layer
surfac
antibodi
captur
agent
place
top
piezoelectr
quartz
crystal
reson
frequenc
chang
measur
target
bind
antibodyco
surfac
allow
labelfre
detect
reprint
copyright
permiss
kierni
et
al
b
surfac
plasmon
reson
spr
biosensor
schemat
compos
channel
specif
antibodi
fix
gold
layer
measur
chang
light
reflect
optic
sourc
allow
potenti
highli
sensit
diagnost
capabl
reprint
copyright
permiss
cooper
c
nanostructur
photon
crystalbas
sensor
function
select
captur
detect
hiv
copi
whole
blood
reprint
copyright
permiss
shafie
et
al
break
junction
function
aptam
captur
cancer
biomark
electr
imped
reprint
copyright
permiss
ilya
et
al
author
manuscript
coarsey
et
al
page
tabl
survey
rtpcr
platform
develop
use
outbreak
perkin
kessel
